EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model

Lorenzo Lance David iD, Moganavelli Singh iD

Pharmaceuticals · 30.12.2025 · 19 (1) · 74

DOI: 10.3390/ph19010074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 30.12.2025. Verfasst von Lorenzo Lance David und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nano-Gene and Drug Delivery Group, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Research on noble metal nanoparticles (NPs) has increased over the past three decades, with advancements in synthesis techniques refining their physicochemical characteristics, including size, shape, and surface chemistry. Bimetallic NPs (BNPs) offer synergistic properties contributed by both metals. Gold (Au) and palladium (Pd) NPs possess low toxicity, high biocompatibility and loading, ease of synthesis and surface modification. Doxorubicin (DOX) and 5-fluorouracil (5-FU) are potent chemotherapeutic drugs but are rapidly metabolised in the body, producing severe side effects, limiting their use. Hence, innovative strategies to mitigate this is needed.

Methods

In this study, AuPd NPs in a core-shell formation were chemically synthesized. The AuPd NPs were conjugated to 5-FU and DOX-encapsulated CS complexes and decorated with the targeting moiety transferrin (Tf).

Results

Transmission electron microscopy and nanoparticle tracking analysis confirmed that the BNPs were spherical, with an average size of 73.4 nm. Functionalized BNPs were able to encapsulate more than 70% of 5-FU and DOX, resulting in a controlled drug release profile at pH 4.2. Cytotoxicity levels in human cancer cells, HeLa (cervical carcinoma) and MCF-7 (breast adenocarcinoma), as well as in non-cancer HEK293 (embryonic kidney) cells, revealed that the Tf-targeted nanocomplexes were HeLa cell-specific, with no significant cytotoxicity in the HEK293 cells. Tf-mediated cellular uptake was confirmed by receptor competition studies in the HeLa cells. Apoptosis and oxidative stress analysis confirmed cell death by apoptosis, consistent with the action of 5-FU and DOX.

Conclusions

This study highlighted the potential of this BNP-nanocomplex as a suitable vehicle for drug delivery.

Schlagwörter

Stichwörter der Autor:innen

5-fluorouracilbimetallic nanoparticleschitosandoxorubicindrug deliveryencapsulationgoldpalladiumtransferrin

Autor:innen und Institutionen

  • Nano-Gene and Drug Delivery Group, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.

ORCID-Profile: Lorenzo Lance David, Moganavelli Singh

Förderung

  • National Research Foundation

Zitieren

APA

David, L. L., & Singh, M. (2025). Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model. Pharmaceuticals, 19(1), 74. https://doi.org/10.3390/ph19010074

Vancouver

David LL, Singh M. Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model. Pharmaceuticals. 2025;19(1):74. doi:10.3390/ph19010074

BibTeX
@article{David2025,
  author = {David, Lorenzo Lance and Singh, Moganavelli},
  title = {Functionalized Core/Shell Gold-Palladium Bimetallic Nanoparticles in Transferrin-Targeted Dual-Drug Delivery in a Cervical Cancer Cell Model},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {19},
  number = {1},
  pages = {74},
  doi = {10.3390/ph19010074}
}
Kostenlos starten →